<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28003368</article-id>
<article-id pub-id-type="pmc">5313114</article-id>
<article-id pub-id-type="publisher-id">M116.766824</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.766824</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Protein Synthesis and Degradation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">Characterization of UBE3B Function</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Braganza</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jianfeng</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Xuemei</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>‖</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yates</surname>
<given-names>Nathan A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>‖</sup>
</xref>
<xref ref-type="aff" rid="aff6">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dey</surname>
<given-names>Nupur B.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrews</surname>
<given-names>Joel</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clark</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zamani</surname>
<given-names>Leila</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiao-hong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>St. Croix</surname>
<given-names>Claudette</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>‡‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O'Sullivan</surname>
<given-names>Roderick</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garcia-Exposito</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brodsky</surname>
<given-names>Jeffrey L.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>§§</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7385-3563</contrib-id>
<name>
<surname>Sobol</surname>
<given-names>Robert W.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>‡</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>§</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>¶</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the <label>‡</label>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, </aff>
<aff id="aff2">the <label>§</label>Hillman Cancer Center, University of Pittsburgh Cancer Institute, </aff>
<aff id="aff3"><label>‖</label>Biomedical Mass Spectrometry Center, School of the Health Sciences, and </aff>
<aff id="aff4"><label>‡‡</label>Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, </aff>
<aff id="aff5">the <label>¶</label>Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama 36604, </aff>
<aff id="aff6">the <label>**</label>Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, and </aff>
<aff id="aff7">the <label>§§</label>Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> Abraham A. Mitchell Distinguished Investigator. To whom correspondence should be addressed: <addr-line>University of South Alabama Mitchell Cancer Institute, 1660 Springhill Ave., Mobile, AL 36604.</addr-line> Tel.: <phone>251-445-9846</phone>; Fax: <fax>251-460-6994</fax>; E-mail: <email>rwsobol@health.southalabama.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by George N. DeMartino</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>10</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>292</volume>
<issue>6</issue>
<fpage>2470</fpage>
<lpage>2484</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc00617002470.pdf"></self-uri>
<abstract>
<p>Recent genome-wide studies found that patients with hypotonia, developmental delay, intellectual disability, congenital anomalies, characteristic facial dysmorphic features, and low cholesterol levels suffer from <underline>K</underline>aufman <underline>o</underline>culocerebrofacial <underline>s</underline>yndrome (KOS, also reported as blepharophimosis-ptosis-intellectual disability syndrome). The primary cause of KOS is autosomal recessive mutations in the gene <italic>UBE3B</italic>. However, to date, there are no studies that have determined the cellular or enzymatic function of UBE3B. Here, we report that UBE3B is a mitochondrion-associated protein with <underline>h</underline>omologous to the <underline>E</underline>6-AP <underline>C</underline>
<underline>t</underline>erminus (HECT) E3 ubiquitin ligase activity. Mutating the catalytic cysteine (C1036A) or deleting the entire HECT domain (amino acids 758–1068) results in loss of UBE3B's ubiquitylation activity. Knockdown of UBE3B in human cells induces changes in mitochondrial morphology and physiology, a decrease in mitochondrial volume, and a severe suppression of cellular proliferation. We also discovered that UBE3B interacts with calmodulin via its N-terminal isoleucine-glutamine (IQ) motif. Deletion of the IQ motif (amino acids 29–58) results in loss of calmodulin binding and a significant increase in the <italic>in vitro</italic> ubiquitylation activity of UBE3B. In addition, we found that changes in calcium levels <italic>in vitro</italic> disrupt the calmodulin-UBE3B interaction. These studies demonstrate that UBE3B is an E3 ubiquitin ligase and reveal that the enzyme is regulated by calmodulin. Furthermore, the modulation of UBE3B via calmodulin and calcium implicates a role for calcium signaling in mitochondrial protein ubiquitylation, protein turnover, and disease.</p>
</abstract>
<kwd-group>
<kwd>calcium</kwd>
<kwd>mitochondria</kwd>
<kwd>oxidative stress</kwd>
<kwd>protein degradation</kwd>
<kwd>reactive oxygen species (ROS)</kwd>
<kwd>ubiquitylation (ubiquitination)</kwd>
<kwd>HECT</kwd>
<kwd>Kaufman oculocerebrofacial syndrome</kwd>
<kwd>super-resolution microscopy</kwd>
<kwd>ubiquitin/proteosome system</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>National Institutes of Health
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>CA148629</award-id>
<award-id>CA047904</award-id>
<award-id>GM087798</award-id>
<award-id>GM75061</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>